arrow_back Trending Legislation
Share share

Faster Tests and Research for New Diseases

This act aims to accelerate the development of new diagnostic tests and treatments for unknown diseases. This means that in the event of a new epidemic, citizens can expect faster access to diagnosis and more effective treatments, enhancing public health security. It will also facilitate access to pathogen samples for researchers, which is crucial for medical advancements.
Key points
Facilitating access to pathogen samples for researchers, speeding up drug and test development.
Supporting rapid creation and dissemination of diagnostic tests for new diseases.
Increasing national preparedness for future health threats, potentially protecting citizens' lives and health.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Promoting ACCESS to Diagnostics Act
Print number: S 3496
Sponsor: Sen. Braun, Mike [R-IN]
Process start date: 2022-01-13
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Faster Tests and Research for New Diseases

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 3496.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-01-13.

What are the main provisions?

Key points include:

  • Facilitating access to pathogen samples for researchers, speeding up drug and test development.
  • Supporting rapid creation and dissemination of diagnostic tests for new diseases.
  • Increasing national preparedness for future health threats, potentially protecting citizens' lives and health.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Braun, Mike [R-IN].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

Analysis and Potential Impact of S 3496

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health